Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum

Neuropathology

Volumn 32, Issue 6, 2012, Pages 595-603

  Takahashi, Makoto ^a   Ishikawa, Kinya ^a   Sato, Nozomu ^a   Obayashi, Masato ^a   Niimi, Yusuke ^a   Ishiguro, Taro ^a   Yamada, Mitsunori ^c,d   Toyoshima, Yasuko ^c   Takahashi, Hitoshi ^c   Kato, Takeo ^e   Takao, Masaki ^b,f   Murayama, Shigeo ^b   Mori, Osamu ^g   Eishi, Yoshinobu ^a   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d National Saigata Medical Center   (Japan)

^e YAMAGATA UNIVERSITY   (Japan)

^f Mihara Memorial Hospital   (Japan)

^g Hatsuishi Hospital   (Japan)

Author keywords

Brain derived neurotrophic factor (BDNF); Immunohistochemistry; Purkinje cell; Quantitative reverse transcription PCR (qRT PCR); Spinocerebellar ataxia type 6 (SCA6)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA;

ARTICLE; CELL GRANULE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PURKINJE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINOCEREBELLAR ATAXIA TYPE 6; SPINOCEREBELLAR DEGENERATION;

AGED; AGED, 80 AND OVER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBELLUM; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PURKINJE CELLS; RNA, MESSENGER; SPINOCEREBELLAR ATAXIAS;

EID: 84870062146     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01302.x     Document Type: Article

References (32)

1. Ishikawa K, Tanaka H, Saito M etal. Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1. Am J Hum Genet 1997; 61: 336-346.
2. Gomez CM, Thompson RM, Gammack JT etal. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997; 42: 933-950.
3. Zhuchenko O, Bailey J, Bonnen P etal. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15: 62-69.
4. Ishikawa K, Fujigasaki H, Saegusa H etal. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet 1999; 8: 1185-1193.
5. Ishikawa K, Owada K, Ishida K etal. Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology 2001; 56: 1753-1756.
6. Yabe I, Sasaki H, Matsuura T etal. SCA6 mutation analysis in a large cohort of the Japanese patients with late-onset pure cerebellar ataxia. J Neurol Sci 1998; 156: 89-95.
7. Takahashi H, Ishikawa K, Tsutsumi T etal. A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6. J Hum Genet 2004; 49: 256-264.
8. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007; 30: 575-621.
9. DiFiglia M, Sapp E, Chase KO etal. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277: 1990-1993.
10. Paulson HL, Perez MK, Trottier Y etal. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
11. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123-131.
12. Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res 2000; 866: 257-261.
13. Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 2007; 81: 294-330.
14. Zuccato C, Ciammola A, Rigamonti D etal. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001; 293: 493-498.
15. Gharami K, Xie Y, An JJ, Tonegawa S, Xu B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J Neurochem 2008; 105: 369-379.
16. Steffan JS, Kazantsev A, Spasic-Boskovic O etal. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 2000; 97: 6763-6768.
17. Nucifora FC, Jr, Sasaki M, Peters MF etal. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001; 291: 2423-2428.
18. McCampbell A, Taylor JP, Taye AA etal. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 2000; 9: 2197-2202.
19. Ishiguro T, Ishikawa K, Takahashi M etal. The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells. Acta Neuropathol 2010; 119: 447-464.
20. Dieni S, Rees S. Distribution of brain-derived neurotrophic factor and TrkB receptor proteins in the fetal and postnatal hippocampus and cerebellum of the guinea pig. J Comp Neurol 2002; 454: 229-240.
21. Gauthier LR, Charrin BC, Borrell-Pages M etal. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004; 118: 127-138.
22. Miyashita T, Tabuchi A, Fukuchi M etal. Interference with activity-dependent transcriptional activation of BDNF gene depending upon the expanded polyglutamines in neurons. Biochem Biophys Res Commun 2005; 333: 1241-1248.
23. Hourez R, Servais L, Orduz D etal. Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci 2011; 31: 11795-11807.
24. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 2008; 7 (Suppl 1): 43-56.
25. Howells DW, Porritt MJ, Wong JY etal. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 2000; 166: 127-135.
26. Ishikawa K, Watanabe M, Yoshizawa K etal. Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6). J Neurol Neurosurg Psychiatry 1999; 67: 86-89.
27. Matsuda N, Lu H, Fukata Y etal. Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite. J Neurosci 2009; 29: 14185-14198.
28. Kawamoto Y, Nakamura S, Nakano S, Oka N, Akiguchi I, Kimura J. Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience 1996; 74: 1209-1226.
29. Kawamoto Y, Nakamura S, Kawamata T, Akiguchi I, Kimura J. Cellular localization of brain-derived neurotrophic factor-like immunoreactivity in adult monkey brain. Brain Res 1999; 821: 341-349.
30. Murer MG, Boissiere F, Yan Q etal. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 1999; 88: 1015-1032.
31. Adachi N, Kohara K, Tsumoto T. Difference in trafficking of brain-derived neurotrophic factor between axons and dendrites of cortical neurons, revealed by live-cell imaging. BMC Neurosci 2005; 6: 42.
32. Kuczewski N, Porcher C, Lessmann V, Medina I, Gaiarsa JL. Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol 2009; 39: 37-49.